Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry
2017 ◽
Vol 137
◽
pp. 78-83
◽
1994 ◽
Vol 661
(1)
◽
pp. 1-5
◽
2000 ◽
Vol 741
(2)
◽
pp. 175-188
◽
1987 ◽
Vol 417
◽
pp. 420-427
◽
2011 ◽
Vol 55
(5)
◽
pp. 1179-1185
◽
1995 ◽
Vol 667
(2)
◽
pp. 241-246
◽
1986 ◽
Vol 382
◽
pp. 167-174
◽
2016 ◽
Vol 1027
◽
pp. 1-10
◽